TYNDALL CAPITAL PARTNERS L P

13F Portfolio Filings

Most recent 13F
Q3 2024
Location
New York, NY
CIK
0001219314
All SEC filings
View on sec.gov
Holdings Value
Quarter Holdings Value ($000) Top Holdings Form Type Date Filed Filing ID
Q3 2024 1 426 CYCN 13F-HR 11/14/2024 000149315224045808
Q2 2024 1 378 CYCN RESTATEMENT 11/27/2024 000149315224047983
Q1 2024 1 527 CYCN 13F-HR 5/15/2024 000149315224019867
Q4 2023 1 550 CYCN 13F-HR 2/14/2024 000149315224006681
Q3 2023 1 505 CYCN 13F-HR 11/14/2023 000149315223041235
Q2 2023 1 0 13F-HR 8/14/2023 000149315223028393
Q1 2023 1 0 13F-HR 5/15/2023 000149315223017360
Q4 2022 1 0 13F-HR 2/14/2023 000149315223004831
Q3 2022 1 0 13F-HR 11/14/2022 000149315222031993
Q2 2022 1 0 13F-HR 8/15/2022 000149315222022870
Q1 2022 1 0 13F-HR 5/16/2022 000149315222013754
Q4 2021 1 0 13F-HR 2/14/2022 000090571822000345
Q3 2021 1 0 13F-HR 11/15/2021 000090571821001496
Q2 2021 1 0 13F-HR 8/16/2021 000090571821001067
Q1 2021 1 0 13F-HR 5/17/2021 000090571821000701
Q4 2020 1 0 13F-HR 2/16/2021 000090571821000279
Q3 2020 1 0 13F-HR 11/16/2020 000090571820001112
Q2 2020 1 0 13F-HR 8/14/2020 000090571820000860
Q1 2020 1 0 13F-HR 5/15/2020 000090571820000458
Q4 2019 2 2,321 MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 2/14/2020 000090571820000216
Q3 2019 3 2,709 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 11/14/2019 000090571819000929
Q2 2019 3 4,920 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 8/14/2019 000090571819000689
Q1 2019 3 5,056 ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 5/15/2019 000090571819000455
Q4 2018 3 3,566 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 2/14/2019 000090571819000234
Q3 2018 3 7,929 ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 11/14/2018 000090571818000938
Q2 2018 3 6,888 ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 8/14/2018 000090571818000754
Q1 2018 3 3,841 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 5/15/2018 000090571818000507
Q4 2017 3 3,474 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 2/14/2018 000090571818000211
Q3 2017 4 7,824 PCOA, ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 11/14/2017 000090571817000966
Q2 2017 4 8,449 PCOA, ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 8/14/2017 000090571817000778
Q1 2017 3 3,477 ONTX, MMAC, ONCONOVA THERAPEUTICS INC 13F-HR 5/15/2017 000090571817000566
Q4 2016 3 2,854 MMAC, ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 2/14/2017 000090571817000231
Q3 2016 2 1,844 ONTX, ONCONOVA THERAPEUTICS INC 13F-HR 11/14/2016 000090571816001753
Q2 2016 1 0 13F-HR 8/15/2016 000090571816001615
Q1 2016 1 0 13F-HR 5/16/2016 000090571816001444
Q4 2015 1 0 13F-HR 2/16/2016 000090571816001213
Q3 2015 1 0 13F-HR 11/16/2015 000090571815000911
Q2 2015 1 0 13F-HR 8/14/2015 000090571815000710
Q1 2015 1 0 13F-HR 5/15/2015 000090571815000459
Q4 2014 1 0 13F-HR 2/17/2015 000090571815000249
Q3 2014 1 0 13F-HR 11/14/2014 000090571814000761
Q2 2014 1 0 13F-HR 8/14/2014 000090571814000541
Q1 2014 1 0 13F-HR 5/15/2014 000090571814000256
Q4 2013 1 0 13F-HR 2/14/2014 000114036114007901
Additional filings from Tyndall Capital Partners L P that have since been restated